Business Description
Lotus Health Group Co
NAICS : 311930
SIC : 2087
ISIN : CNE000000WY0
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2238.2 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 27.26 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.34 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.7 | |||||
3-Year EBITDA Growth Rate | -14.4 | |||||
3-Year Book Growth Rate | 39 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.15 | |||||
9-Day RSI | 50.51 | |||||
14-Day RSI | 47.2 | |||||
6-1 Month Momentum % | -28.82 | |||||
12-1 Month Momentum % | 81.45 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 1.16 | |||||
Days Inventory | 19.99 | |||||
Days Sales Outstanding | 20.21 | |||||
Days Payable | 191.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.1 | |||||
Shareholder Yield % | -0.2 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 16.8 | |||||
Operating Margin % | 6.61 | |||||
Net Margin % | 4.62 | |||||
FCF Margin % | -2.06 | |||||
ROE % | 6.38 | |||||
ROA % | 3.81 | |||||
ROIC % | 12.5 | |||||
ROC (Joel Greenblatt) % | 45.54 | |||||
ROCE % | 10.1 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 77.14 | |||||
PE Ratio without NRI | 77.14 | |||||
Price-to-Owner-Earnings | 144 | |||||
PS Ratio | 3.78 | |||||
PB Ratio | 5.18 | |||||
Price-to-Tangible-Book | 5.64 | |||||
EV-to-EBIT | 51.54 | |||||
EV-to-EBITDA | 51.54 | |||||
EV-to-Revenue | 3.21 | |||||
EV-to-FCF | -155.84 | |||||
Price-to-Median-PS-Value | 1.63 | |||||
Price-to-Graham-Number | 4.41 | |||||
Price-to-Net-Current-Asset-Value | 9.6 | |||||
Price-to-Net-Cash | 19.64 | |||||
Earnings Yield (Greenblatt) % | 1.94 | |||||
FCF Yield % | -0.53 | |||||
Forward Rate of Return (Yacktman) % | 20.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Lotus Health Group Co Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,990.457 | ||
EPS (TTM) (Â¥) | 0.056 | ||
Beta | 1.19 | ||
Volatility % | 75.66 | ||
14-Day RSI | 47.2 | ||
14-Day ATR (Â¥) | 0.191515 | ||
20-Day SMA (Â¥) | 4.3435 | ||
12-1 Month Momentum % | 81.45 | ||
52-Week Range (Â¥) | 2.66 - 8.24 | ||
Shares Outstanding (Mil) | 1,793.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Lotus Health Group Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Lotus Health Group Co Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Lotus Health Group Co Frequently Asked Questions
What is Lotus Health Group Co(SHSE:600186)'s stock price today?
When is next earnings date of Lotus Health Group Co(SHSE:600186)?
Does Lotus Health Group Co(SHSE:600186) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |